ArticleJournal of thoracic disease2019
Trends in lung cancer screening in the United States, 2016-2017.
Article in Journal of thoracic disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05824273 (Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations), which is not on this map. Cited by 49 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations
Who cites it
49 citing papers in PubMed.
- Feasibility, acceptability, and preliminary impact of a text messaging intervention to increase the uptake of lung cancer screening among Latinos: single-arm pilot study.Journal of thoracic disease · 2026Article
- Exploring Clinical Pathways to a Metastatic Lung Cancer Diagnosis: A Latent Class Analysis Using North Carolina Multipayer Claims Data.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Design of the first national lung cancer screening program in the European Union: the Croatian Model.European radiology · 2026Article
- Article
- Risk factors and survival associated with lung cancer recurrence after curative-intent surgery: beyond TNM pathological staging.Journal of thoracic disease · 2025Article
- Multi-level factors associated with low dose computed tomography lung cancer screening in the United States.Journal of the National Medical Association · 2025Article
- In Vitro Cytotoxic and Molecular Docking Studies of the Network Pharmacology Approach From Bioactive Compounds ofAdvances in pharmacological and pharmaceutical sciences · 2025Article
- Incidental Coronary Artery Calcification and the Risk of Major Adverse Cardiovascular Outcomes.Cureus · 2024Article
- A Brief Report of Lung Cancer Screening Utilization Before, During, and in the Later Stages of the COVID-19 Pandemic in the United States.JTO clinical and research reports · 2024Article
- Clinical characteristics and prognosis of non-high-risk patients with incidental stage T1 lung cancer: A prospective cohort study.Clinical and experimental medicine · 2024Article
- Using Telehealth to Increase Lung Cancer Screening Referrals for At-Risk Veterans in Rural Communities.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2024Article
- Advanced Bronchoscopic Diagnostic Techniques in Lung Cancer.Tuberculosis and respiratory diseases · 2024Article
- Outcomes in Incidentally Versus Screening Detected Stage I Lung Cancer Surgery Patients.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024Article
- Understanding the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos: A qualitative study.Frontiers in oncology · 2024Article
- Assessment of interobserver concordance in radiomic tools for lung nodule classification, with a focus on BRODERS and SILA.Scientific reports · 2023Article
- Article
- Review
- Article
- Training and Dissemination of Lung Cancer Education Curriculum Among Community Health Advisors in the Deep South: a Program Evaluation.Journal of cancer education : the official journal of the American Association for Cancer Education · 2023Article
- Opportunities and Challenges in Lung Cancer Screening Implementation: A Narrative Review.Current challenges in thoracic surgery · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung cancer is the most common cancer killer annually, yet the overall rate of eligible patients who undergo screening with low-dose computed tomography (LDCT) is low. Our goal was to determine factors which were associated with the probability of obtaining lung cancer screening.
methodsThe Clinformatics Data Mart (CDM) database, a national commercial health insurance database with over 18,000,000 enrollees, was queried to determine the rate of LDCT screening and factors which influenced receiving LDCT screening. All enrollees between the ages of 55 and 77 from 2016 to 2017 were included. Demographics, history of tobacco exposure and state smoking statistics were recorded.
resultsAll 8,350,197 enrollees aged 55-77 were included in the study. Among enrollees, the rate of screening increased throughout 2016 and early 2017 and then appeared to stabilize. In the second half of 2017 the LDCT rate was approximately 6 per 1,000 enrollees per year, and was increasing at a slope of 0.1 additional LDCT per 1,000 enrollees per year. There was marked geographic variation, with 5-fold differences in LDCT rates between different regions. There was no correlation between smoking rate and LDCT rate at the state level (r=0.02; P=0.87). Enrollees aged 65-69 were most likely to be screened (OR =1.53; 1.45-1.61) compared to enrollees aged 55-59.
conclusionsThe rate of LDCT screening is increasing very slowly with time, and most eligible patients are not screened. Further studies are needed to determine the reasons for low screening rates, and the marked geographic variation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.